Aeglea BioTherapeutics (AGLE) Q3 2023 Earnings

Nov 9Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-9.34
-6.28
-3.21
-0.15

Details

Expected EPS
-0.84
Actual EPS
-9.34
Surprise EPS
-8.5
Surprise Percent
-1,011.9%

Description

⁨Aeglea BioTherapeutics⁩ (⁦AGLE⁩) has reported earnings of ⁦-9.34⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts